Sunifiram

Sunifiram

Nombre del producto Sunifiram
Sinónimos DM-235; DM235; 1-Benzoyl-4-propanoylpiperazine; 1-(4-Benzoylpiperazin-1-yl)propan-1-one; 1-Benzoyl-4-(1-oxopropyl)piperazine
Número CAS 314728-85-3
Fórmula molecular C₁₄H₁₈N₂O₂
Peso molecular 246.30 g/mol
Apariencia Polvo cristalino de color blanco a blanquecino
Ensayo (HPLC) ≥ 99,01 TP3T
Punto de fusión 86–89°C
Pérdida por secado ≤ 0,51 TP3T
Residuo tras la combustión ≤ 0,11 TP3T
Metales pesados ≤ 10 ppm
Almacenamiento En un lugar fresco, seco, hermético y protegido de la luz
Vida útil 36 meses

What is Sunifiram?

Sunifiram (developmental code DM-235) is a potente compuesto nootrópico belonging to the piperazine class.

It was developed as a next-generation cognitive enhancer with significantly higher potency than the classic racetam family (piracetam, aniracetam).

Sunifiram is structurally distinct from racetams but shares similar glutamatergic mechanisms.

Sunifiram is estimated to be aproximadamente 1.000 veces más potente que el piracetam en modelos animales.

It acts as a positive allosteric modulator of AMPA receptors and may also influence nicotinic acetylcholine receptors (nAChRs).

Unlike many racetams, sunifiram does not require metabolic activation.

buy Sunifiram

Sunifiram Nootropic Supplement

Sunifiram was developed by researchers at the University of Florence, Italy, as part of a series of potent ampakine-like compounds. Along with Unifiram (DM-232), it was designed to overcome the low potency limitations of traditional racetams. Preclinical studies demonstrated cognitive-enhancing effects at microgram-per-kilogram doses—orders of magnitude lower than piracetam (which requires milligram-per-kilogram doses).

Mechanism of Action (Research Context)

Sunifiram exerts its effects primarily through glutamatergic modulation:

Itinerario Proposed Mechanism Cognitive Effect
AMPA receptor positive allosteric modulation Enhances glutamate-induced currents; increases synaptic plasticity Memory consolidation, learning, attention
Nicotinic acetylcholine receptor (nAChR) modulation May influence α7 nAChR subtypes (preliminary) Focus, working memory
Cholinergic enhancement Indirect (via glutamatergic-cholinergic interaction) Learning, memory

Applications & Market Segments

1. Research & Development (Primary Market)

Solicitud Descripción Usuarios finales
AMPA receptor research Studying positive allosteric modulation of AMPA receptors Academic neuroscience, pharmacology labs
Cognitive enhancement studies In vitro and animal models of memory, learning, attention Behavioral neuroscience research
Scopolamine-induced amnesia models Reversal of cholinergic deficit (Alzheimer’s research models) Neuropharmacology, drug discovery
Comparative nootropic research Potency comparisons with racetams and other ampakines Investigación y desarrollo farmacéutico

2. Structure-Activity Relationship (SAR) Studies

Research Focus Solicitud
Piperazine vs. pyrrolidone scaffolds Comparing structural requirements for AMPA modulation
Derivative synthesis Developing novel sunifiram analogs with improved properties
Receptor binding studies Characterizing AMPA receptor subtype selectivity

3. Analytical Reference

Solicitud Descripción
Reference standard HPLC, LC-MS method development
Impurity profiling For custom synthesis quality control
Stability studies Forced degradation, long-term stability

Proveedor: LyvBio Co., Ltd.

LyvBio S.L. is a GMP-certified supplier of high-purity Sunifiram for research and development applications.

Capacidad de suministro:

  • Ensayo (HPLC): ≥99,01 TP3T

  • Formulario: Polvo cristalino

  • Capacidad mensual: 5+ kg

  • Cantidades al por mayor: 1g – 5kg

  • Plazo de entrega: 3-5 días (muestras), 10-15 días (a granel)

  • Documentación: COA, MSDS,HNMR, HPLC chromatogram, stability data

Control de calidad:

  • Pureza determinada por HPLC con detección UV

  • Se han analizado los disolventes residuales (cumple con la norma USP )

  • Metales pesados analizados (ICP-MS)

  • Confirmación estructural (RMN previa solicitud)

📧 Consultas: info@lyvbio.com

buy Sunifiram

Especificaciones (detalladas)

Parámetro Especificaciones Método de ensayo
Ensayo (HPLC) ≥ 99,01 TP3T HPLC-UV (254 nm)
Apariencia Polvo cristalino de color blanco a blanquecino Visual
Identificación Tiempo de retención por HPLC, RMN (bajo pedido) HPLC / RMN
Punto de fusión 86–89°C USP
Pérdida por secado ≤ 0,51 TP3T USP
Residuo tras la combustión ≤ 0,11 TP3T USP
Metales pesados Pb ≤ 10 ppm; As ≤ 2 ppm; Cd ≤ 1 ppm; Hg ≤ 0,1 ppm ICP-MS
Sustancias relacionadas Impureza individual ≤ 0,51 TP3T; Total ≤ 1,01 TP3T HPLC-UV
Disolventes residuales Conoce la norma USP GC
Tamaño de las partículas De 95% a malla 80 Análisis granulométrico

 Preguntas frecuentes

Q: Is Sunifiram the same as Piracetam or Aniracetam?
A: No. Sunifiram is a structurally distinct piperazine derivative, not a racetam. It is estimated to be approximately 1,000 times more potent than piracetam in animal models.

Q: Is Sunifiram FDA-approved for medical use?
R: No. Sunifiram has no approved medical use in any major market. It is a research chemical for laboratory use only. No human clinical trials have been published.

Q: What is the difference between Sunifiram and Unifiram (DM-232)?
A: Both are piperazine derivatives developed by the same research group. They have similar potency (~1,000x piracetam) but different chemical structures (different substituents on the piperazine ring). Unifiram is CAS 219694-40-3.

Q: What is the mechanism of action of Sunifiram?
A: Sunifiram is believed to act as a positive allosteric modulator of AMPA receptors (an ampakine). It may also influence nicotinic acetylcholine receptors. Detailed receptor binding studies are limited.

P: ¿Cuál es el rango de dosis eficaz en los estudios con animales?
A: Published studies report cognitive-enhancing effects at 0.01–0.1 mg/kg (oral) in rodents—approximately 1,000 times more potent than piracetam.

Q: Are there human clinical trials for Sunifiram?
R: No. No human clinical trials have been published. Sunifiram is a research chemical only.

Póngase en contacto con LyvBio Co., Ltd.

📧 Correo electrónico: info@lyvbio.com
🌐 Página web: https://www.lyvbio.com

MANTENTE EN CONTACTO

Solicitud de presupuesto

Nuestra dirección

Calle Main, 280, Xi'an, Shaanxi, China

×